LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Sight Sciences (NASDAQ: SGHT)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SGHT Sight Sciences
HAYDEN JEREMY B. / officer: Chief Legal Officer
04/02/2025
Sell
$2.31
9,395
$22K
275,481
NASDAQ SGHT Sight Sciences
Badawi Paul / director, officer: President and CEO
04/01/2025
Sell
$2.30
24,174
$56K
6.01M
NASDAQ SGHT Sight Sciences
Link Matthew / officer: Chief Commercial Officer
04/02/2025
Sell
$2.31
5,042
$12K
830,551
NASDAQ SGHT Sight Sciences
Badawi David / director, officer: Chief Technology Officer
04/01/2025
Sell
$2.30
5,980
$14K
1.84M
NASDAQ SGHT Sight Sciences
Bauerlein Alison / officer: Chief Financial Officer
04/02/2025
Sell
$2.31
19,397
$45K
649,794
NASDAQ SGHT Sight Sciences
Raheja Manohar K. / officer: EVP, Research & Development
03/13/2025
Buy
$2.60
10,000
$26K
155,000
NASDAQ SGHT Sight Sciences
Raheja Manohar K. / officer: EVP, Research & Development
03/12/2025
Buy
$2.73
10,000
$27K
145,000
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
03/12/2025
Buy
$2.77
243,000
$673K
5.09M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
03/11/2025
Buy
$2.71
150,000
$407K
4.84M
NASDAQ SGHT Sight Sciences
Encrantz Staffan / director, 10 percent owner:
03/10/2025
Buy
$2.53
120,000
$304K
4.69M